Page last updated: 2024-09-02

fingolimod hydrochloride and Retinal Vein Occlusion

fingolimod hydrochloride has been researched along with Retinal Vein Occlusion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Do, JL; Patel, VR1
Casanova, B; Díaz-Llopis, M; España-Gregori, E; Gallego-Pinazo, R; Pardo-López, D1

Other Studies

2 other study(ies) available for fingolimod hydrochloride and Retinal Vein Occlusion

ArticleYear
Branch retinal vein occlusion associated with fingolimod treatment for multiple sclerosis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2021, Volume: 56, Issue:1

    Topics: Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Multiple Sclerosis; Retinal Vein; Retinal Vein Occlusion

2021
Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2011, Volume: 31, Issue:3

    Topics: Blindness; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis; Propylene Glycols; Retinal Vein; Retinal Vein Occlusion; Sphingosine

2011